Latest INVO reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
INVO Bioscience logo
INVO Bioscience INVO
$ 0.87 0.81%

INVO Bioscience Balance Sheet 2011-2024 | INVO

Annual Balance Sheet INVO Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

5.69 M 1.81 M -3.56 M -9.32 M -781 K 183 K 317 K 200 K -271 K 522 K 457 K 468 K 487 K

Long Term Debt

5.52 M 1.67 M 1.9 M - 355 K - 132 K 132 K - - - - -

Long Term Debt Current

398 K 232 K 222 K 22.7 K 21.4 K - - - - - - - -

Total Non Current Liabilities

- - - 2.92 M 4.01 M - 132 K 132 K - - - - -

Total Current Liabilities

8.22 M 3.41 M 1.25 M 2.29 M 1.5 M 3.5 M 5.13 M 4.77 M 4.34 M - - - -

Total Liabilities

20 M 5.08 M 3.16 M 5.2 M 5.51 M 3.5 M 5.26 M 4.9 M 4.34 M 4.47 M 3.94 M 3.5 M 3.05 M

Deferred Revenue

409 K 120 K 5.9 K 714 K 714 K 18.9 K - - - - - - -

Retained Earnings

-57.8 M -49.8 M -38.9 M -32.2 M -23.9 M -21.7 M -18.6 M -17.9 M -15.8 M -10.9 M -9.13 M -8.37 M -7.7 M

Total Assets

20.9 M 4.1 M 10.5 M 10.9 M 1.8 M 777 K 266 K 286 K 580 K 108 K 123 K 125 K 128 K

Cash and Cash Equivalents

232 K 90.1 K 5.68 M 10.1 M 1.24 M 212 K 25.8 K 152 K 492 K 18.6 K - - -

Book Value

893 K -978 K 7.31 M 5.74 M -3.71 M -2.72 M -4.99 M -4.62 M -3.76 M -4.36 M -3.81 M -3.37 M -2.93 M

Total Shareholders Equity

893 K -978 K 7.31 M 5.74 M -3.71 M -2.72 M -4.99 M -4.62 M -3.76 M -4.36 M - - -

All numbers in USD currency

Quarterly Balance Sheet INVO Bioscience

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

3.14 M 5.52 M 5.62 M 3.87 M 1.61 M 1.67 M 1.73 M 1.79 M 1.84 M 1.9 M 1.33 M 1.36 M 52.8 K 58.6 K 58.6 K 58.6 K 58.6 K 81.5 K 81.5 K 81.5 K 81.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

18.3 M 20 M 19.1 M 8.34 M 6.06 M 5.08 M 3.39 M 3.07 M 2.93 M 3.16 M 5.79 M 5.57 M 4.59 M 5.2 M 5.2 M 5.2 M 5.2 M 5.51 M 5.51 M 5.51 M 5.51 M 3.5 M 3.5 M 3.5 M 5.22 M 5.26 M 5.26 M 5.26 M 5.26 M 4.9 M 4.9 M 4.9 M 4.9 M 4.34 M 4.3 M 4.34 M 4.34 M 4.47 M 4.34 M 4.22 M 4.05 M 3.94 M 3.96 M 3.77 M 3.72 M 3.5 M 3.49 M 3.28 M 3.18 M 3.05 M 3.06 M 3.06 M -

Deferred Revenue

513 K 409 K 230 K 161 K 46.7 K 120 K 98.7 K 77.4 K 5.79 K 5.9 K 714 K 714 K 714 K 714 K 714 K 714 K 714 K 714 K 714 K 714 K 714 K 18.9 K 18.9 K 18.9 K 18.9 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-59.4 M -57.8 M -55.8 M -54.6 M -52.3 M -49.8 M -47 M -44.5 M -41.7 M -38.9 M -38.7 M -36.5 M -34.7 M -32.2 M -32.2 M -32.2 M -32.2 M -23.9 M -23.9 M -23.9 M -23.9 M -21.7 M -21.7 M -21.7 M -21.7 M -18.6 M -18.6 M -18.6 M -18.6 M -17.9 M -17.9 M -17.9 M -17.9 M -15.8 M -15.6 M -15.8 M -15.8 M -10.9 M -9.55 M -9.43 M -9.24 M -9.13 M -8.99 M -8.77 M -8.67 M -8.37 M -8.32 M -8.08 M -7.94 M -7.7 M -7.51 M -7.41 M -

Total Assets

18.3 M 20.9 M 19.5 M 6.64 M 6.15 M 4.1 M 4.68 M 6.42 M 8.52 M 10.5 M 8.15 M 9.93 M 10.2 M 10.9 M 10.9 M 10.9 M 10.9 M 1.8 M 1.8 M 1.8 M 1.8 M 777 K 777 K 777 K 777 K 266 K 266 K 266 K 266 K 286 K 286 K 286 K 286 K 580 K 199 K 580 K 580 K 108 K 102 K 106 K 115 K 123 K 115 K 115 K 117 K 125 K 140 K 150 K 128 K 128 K 135 K 152 K -

Cash and Cash Equivalents

475 K 232 K 1.06 M 112 K 2.19 M 90.1 K 286 K 1.96 M 3.84 M 5.68 M 4.71 M 6.64 M 8.42 M 10.1 M 10.1 M 10.1 M 10.1 M 1.24 M 1.24 M 1.24 M 1.24 M 212 K 212 K 212 K 212 K 25.8 K 25.8 K 25.8 K 25.8 K 152 K 152 K 152 K 152 K 492 K 492 K 492 K 492 K 18.6 K 6.27 K 8.63 K 7.26 K 18 K 7.5 K 2.28 K 687 7.19 K 27.7 K 31.5 K 887 403 2.24 K 9.7 K -

Book Value

10.2 K 893 K 373 K -1.71 M 88.5 K -978 K 1.29 M 3.36 M 5.59 M 7.31 M 2.36 M 4.36 M 5.6 M 5.74 M 5.74 M 5.74 M 5.74 M -3.71 M -3.71 M -3.71 M -3.71 M -2.72 M -2.72 M -2.72 M -4.44 M -4.99 M -4.99 M -4.99 M -4.99 M -4.62 M -4.62 M -4.62 M -4.62 M -3.76 M -4.1 M -3.76 M -3.76 M -4.36 M -4.24 M -4.12 M -3.93 M -3.81 M -3.84 M -3.65 M -3.6 M -3.37 M -3.35 M -3.13 M -3.05 M -2.93 M -2.93 M -2.9 M -

Total Shareholders Equity

10.2 K 893 K 373 K -1.71 M 88.5 K -978 K 1.29 M 3.36 M 5.59 M 7.31 M 2.36 M 4.36 M 5.6 M 5.74 M -3.9 M 5.74 M 5.74 M -3.71 M -3.71 M -3.71 M -3.71 M -2.72 M -2.72 M -2.72 M -2.72 M -4.99 M -4.99 M -4.99 M -4.99 M -4.62 M -4.62 M -4.62 M -4.62 M -3.76 M -3.76 M -3.76 M -3.76 M -4.36 M -4.24 M -4.12 M -3.93 M -3.81 M -3.84 M -3.65 M -3.6 M -3.37 M -3.35 M -3.13 M -3.05 M -2.93 M -2.93 M -2.9 M -

All numbers in USD currency